EMEA (Europe, Middle East and Africa) Microneedles for Trans / Intradermal Drug Delivery Market Report 2017

November 2017 | 104 pages | ID: E3E334F4630EN
QYResearch

Abstracts

In this report, the EMEA Microneedles for Trans / Intradermal Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Microneedles for Trans / Intradermal Drug Delivery for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Microneedles for Trans / Intradermal Drug Delivery market competition by top manufacturers/players, with Microneedles for Trans / Intradermal Drug Delivery sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Becton Dickinson
• Nanopass Technologies
• Radius Health
• Clearside Biomedical
• Dr. Prausnitz Group
• Zosano Pharma
• Corium International
• Circassia
• Valeritas, Inc.
• BD Medical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Solid Microneedles
• Hollow Microneedles
• Dissolvable Microneedles

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Drugs
• Vaccines
• Proteins
• Peptides
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Microneedles for Trans / Intradermal Drug Delivery Market Report 2017

1 MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Microneedles for Trans / Intradermal Drug Delivery
1.2 Classification of Microneedles for Trans / Intradermal Drug Delivery
  1.2.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Solid Microneedles
  1.2.4 Hollow Microneedles
  1.2.5 Dissolvable Microneedles
1.3 EMEA Microneedles for Trans / Intradermal Drug Delivery Market by Application/End Users
  1.3.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Drugs
  1.3.3 Vaccines
  1.3.4 Proteins
  1.3.5 Peptides
  1.3.6 Others
1.4 EMEA Microneedles for Trans / Intradermal Drug Delivery Market by Region
  1.4.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Microneedles for Trans / Intradermal Drug Delivery (2012-2022)
  1.5.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2012-2022)

2 EMEA MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Market Competition by Players/Manufacturers
  2.1.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Microneedles for Trans / Intradermal Drug Delivery Sale Price by Players (2012-2017)
2.2 EMEA Microneedles for Trans / Intradermal Drug Delivery (Volume and Value) by Type/Product Category
  2.2.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Microneedles for Trans / Intradermal Drug Delivery Sale Price by Type (2012-2017)
2.3 EMEA Microneedles for Trans / Intradermal Drug Delivery (Volume) by Application
2.4 EMEA Microneedles for Trans / Intradermal Drug Delivery (Volume and Value) by Region
  2.4.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Price by Region (2012-2017)

3 EUROPE MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Microneedles for Trans / Intradermal Drug Delivery Sales and Value (2012-2017)
  3.1.1 Europe Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2012-2017)
3.2 Europe Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Type
3.3 Europe Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Application
3.4 Europe Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Microneedles for Trans / Intradermal Drug Delivery Sales Volume by Countries (2012-2017)
  3.4.2 Europe Microneedles for Trans / Intradermal Drug Delivery Revenue by Countries (2012-2017)
  3.4.3 Germany Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.4 France Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.5 UK Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.6 Russia Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.7 Italy Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)

4 MIDDLE EAST MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Microneedles for Trans / Intradermal Drug Delivery Sales and Value (2012-2017)
  4.1.1 Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2012-2017)
4.2 Middle East Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Type
4.3 Middle East Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Application
4.4 Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  4.4.4 Israel Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  4.4.5 UAE Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  4.4.6 Iran Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)

5 AFRICA MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Microneedles for Trans / Intradermal Drug Delivery Sales and Value (2012-2017)
  5.1.1 Africa Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2012-2017)
5.2 Africa Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Type
5.3 Africa Microneedles for Trans / Intradermal Drug Delivery Sales and Market Share by Application
5.4 Africa Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Microneedles for Trans / Intradermal Drug Delivery Sales Volume by Countries (2012-2017)
  5.4.2 Africa Microneedles for Trans / Intradermal Drug Delivery Revenue by Countries (2012-2017)
  5.4.3 South Africa Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate (2012-2017)

6 EMEA MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Becton Dickinson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Nanopass Technologies
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Radius Health
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Clearside Biomedical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dr. Prausnitz Group
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Zosano Pharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Corium International
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Corium International Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Circassia
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Circassia Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Valeritas, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 BD Medical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Microneedles for Trans / Intradermal Drug Delivery Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Microneedles for Trans / Intradermal Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Microneedles for Trans / Intradermal Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Microneedles for Trans / Intradermal Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Microneedles for Trans / Intradermal Drug Delivery Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA MICRONEEDLES FOR TRANS / INTRADERMAL DRUG DELIVERY MARKET FORECAST (2017-2022)

11.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Microneedles for Trans / Intradermal Drug Delivery Price and Trend Forecast (2017-2022)
11.2 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Microneedles for Trans / Intradermal Drug Delivery Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Forecast by Type (2017-2022)
11.7 EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Microneedles for Trans / Intradermal Drug Delivery
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Solid Microneedles Product Picture
Figure Hollow Microneedles Product Picture
Figure Dissolvable Microneedles Product Picture
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Microneedles for Trans / Intradermal Drug Delivery by Application in 2016
Figure Drugs Examples
Table Key Downstream Customer in Drugs
Figure Vaccines Examples
Table Key Downstream Customer in Vaccines
Figure Proteins Examples
Table Key Downstream Customer in Proteins
Figure Peptides Examples
Table Key Downstream Customer in Peptides
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Volume and Growth Rate (2012-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Share by Players (2012-2017)
Figure 2016 Microneedles for Trans / Intradermal Drug Delivery Sales Share by Players
Figure 2017 Microneedles for Trans / Intradermal Drug Delivery Sales Share by Players
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) by Players (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Share by Players (2012-2017)
Table 2016 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Share by Players
Table 2017 EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Share by Players
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Share by Type (2012-2017)
Figure Sales Market Share of Microneedles for Trans / Intradermal Drug Delivery by Type (2012-2017)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Type (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Microneedles for Trans / Intradermal Drug Delivery by Type in 2016
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Share by Application (2012-2017)
Figure Sales Market Share of Microneedles for Trans / Intradermal Drug Delivery by Application (2012-2017)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Application in 2016
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Share by Region (2012-2017)
Figure Sales Market Share of Microneedles for Trans / Intradermal Drug Delivery by Region (2012-2017)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in 2016
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Microneedles for Trans / Intradermal Drug Delivery by Region (2012-2017)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share Regions in 2016
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate (2012-2017)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Type (2012-2017)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Market Share by Type (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Market Share by Type in 2016
Table Europe Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Application (2012-2017)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Market Share by Application (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Market Share by Application in 2016
Table Europe Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Countries (2012-2017)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Countries in 2016
Table Europe Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) by Countries (2012-2017)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries in 2016
Figure Germany Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure France Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure UK Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Type (2012-2017)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Market Share by Type (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Market Share by Type (2012-2017)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Applications (2012-2017)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Market Share by Applications (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Application in 2016
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Volume Market Share by Countries in 2016
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) by Countries (2012-2017)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries in 2016
Figure Saudi Arabia Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Type (2012-2017)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Type (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Type (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Type in 2016
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) by Application (2012-2017)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Application (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Application (2012-2017)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales Volume (K Units) by Countries (2012-2017)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Countries (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share by Countries in 2016
Table Africa Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) by Countries (2012-2017)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries (2012-2017)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share by Countries in 2016
Figure South Africa Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Table Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Becton Dickinson Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Nanopass Technologies Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Radius Health Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Radius Health Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Radius Health Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Clearside Biomedical Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Dr. Prausnitz Group Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Zosano Pharma Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Corium International Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Corium International Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Corium International Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Corium International Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Corium International Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Circassia Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Circassia Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Circassia Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Circassia Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Circassia Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure Valeritas, Inc. Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table BD Medical Microneedles for Trans / Intradermal Drug Delivery Basic Information List
Table BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate (2012-2017)
Figure BD Medical Microneedles for Trans / Intradermal Drug Delivery Sales Market Share in EMEA (2012-2017)
Figure BD Medical Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microneedles for Trans / Intradermal Drug Delivery
Figure Manufacturing Process Analysis of Microneedles for Trans / Intradermal Drug Delivery
Figure Microneedles for Trans / Intradermal Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Microneedles for Trans / Intradermal Drug Delivery Major Manufacturers in 2016
Table Major Buyers of Microneedles for Trans / Intradermal Drug Delivery
Table Distributors/Traders List
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Market Share Forecast by Region (2017-2022)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share Forecast by Region (2017-2022)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Sales Market Share Forecast by Countries (2017-2022)
Table Europe Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Sales Market Share Forecast by Countries (2017-2022)
Table Africa Microneedles for Trans / Intradermal Drug Delivery Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Microneedles for Trans / Intradermal Drug Delivery Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Market Share Forecast by Type (2017-2022)
Table EMEA Microneedles for Trans / Intradermal Drug Delivery Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Microneedles for Trans / Intradermal Drug Delivery Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources